Rahsaan Thompson Sells $438K of Zevra Therapeutics Inc (ZVRA) — SEC Form 4, Jun 23, 2026

Open-Market Net Sale · SEC Form 4

−$438,304

10b5-1 Plan (Partial)

Equity position changed by +38.8%

Reporting Owner

Rahsaan Thompson

Officer

TXN 2026-06-22 · FILED 2026-06-23

Equity Position 115K sh 82,682 → 114,792

Equity Change +38.8% shares held after vs before

Filing Lag 1 business day within 2-day SEC deadline

Form 4 · Statement of Changes in Beneficial Ownership

Zevra Therapeutics Inc

ZVRA CIK 0001434647

Reporting Owner

Name	Relationship
Rahsaan Thompson CIK 0001788524	Officer

Rahsaan Thompson at Zevra Therapeutics Inc Full insider history

Bought (12 mo) —

Sold (12 mo) $969,360

More from this insider at Zevra Therapeutics Inc

Non-Derivative Securities Transactions

Title	Date	Type	Shares	Price	Net Total	Post-Txn	Ownership
Common StockF1	2026-06-21	M - Exercise	66,667 A		—	114,792	Direct
Common StockF2 F3	2026-06-22	S - Sale 10b5-1	34,557 D	$12.68	-$438,304	80,235	Direct

Derivative Securities Transactions

Title	Strike	Date	Type	Shares	Price	Expiration	Underlying	Ownership
Restricted Stock UnitF1 F4 F4		2026-06-21	M - Exercise	66,667 D	$0.00		66,667 Common Stock	Direct

Footnotes (4)

F1: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. Show more
F2: Adoption date of referenced 10b5-1(c) plan is: 01-08-2026. Show more
F3: This transaction was executed in multiple trades at prices ranging from $12.53 to $13.19. The price reported reflects the weighted average sale price. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer or any security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected. Show more
F4: The first and second tranches of the restricted stock units vested and settled on June 21, 2025 and June 21, 2026, respectively, and the remaining tranche of the restricted stock units will vest and settle on the next anniversary thereafter, subject to the Reporting person's continued service through such vesting date. Show more

Institutional Holders

Largest by reported value

5%+ Holders · 13D/G 4 filers

Latest Schedule 13D/G per filer; stakes the filer reported closed are left out.

Other insiders at Zevra Therapeutics Inc

GET /v1/forms/4/0001434647-26-000057 API docs